Bdolah Y, Palomaki GE, Yaron Y, Bdolah-Abram T, Goldman M, Levine RJ, Sachs BP, Haddow JE, Karumanchi SA: Circulating angiogenic proteins in trisomy 13. Am J Obstet Gynecol, 194:239-245, 2006.

Canick JA, Lambert-Messerlian G, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D’Alton ME for the First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium. Comparison of serum markers in first-trimester Down syndrome screening. Obstet Gynecol, 108:1192-1199, 2006.

Craig WY, Haddow JE, Palomaki GE, Kelley RI, Kratz LE, Shackleton CHL, Marcos J, Tint GS, Roberson M, MacRae AR, Nowaczyk MJ, Kloza EM, Irons MB: Identifying Smith-Lemli-Optiz syndrome in conjunction with prenatal screening for Down’s syndrome. Prenat Diagn, 26:842-849, 2006.

Haddow JE, Palomaki GE, McClain MR: Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol, 107:205-206, 2006.

Haddow JE, McClain MR, Palomaki GE, Kloza EM, Williams J: Screening for thyroid disorders during pregnancy: Results of a survey in Maine. Am J Obstet Gynecol , 194:471-474, 2006.

Kavsak PA, MacRae AR, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS: The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of myocardial infarction. Am Heart J , 152:118-125, 2006.

Kavsak PA, MacRae AR, Palomaki GE, Newman AM, Ko DT, Lustig V, Tu JV, Jaffe AS: Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of tropin-naive emergency department patients. Clin Chem, 52:2028-2035, 2006.

Lambert-Messerlian GM, Eklund EE, Malone FD, Palomaki GE, Canick JA, D’Alton ME: Stability of first- and second-trimester serum markers after storage and shipment. Prenat Diagn, 26:17-21, 2006.

MacRae AR, Kavsak PA, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS: Assessing the requirement for the 6-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin Chem, 52:812-818, 2006.

Palomaki GE, Wright DE, Summers AM, Neveux LM, Meier C, O'Donnell A, Huang T, Knight GJ, Haddow JE: Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: A validation study. Prenat Diagn, 26:730-739, 2006.

Palomaki GE, Knight GJ, Neveux LM, Haddow JE, Pandian R: First-trimester Down syndrome screening (Response to Hallahan). Clin Chem, 52:161, 2006.

Palomaki GE, Steinort K, Knight GJ, Haddow JE: Comparing three screening strategies for combining first- and second-trimester Down syndrome markers. Obstet Gynecol, 107:367-375, 2006.

Palomaki GE, McClain MR, Steinort K, Sifri R, LoPresti L, Haddow JE: Screen positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a cohort of 21- to 55-year-old women. Genet Med, 8:161-168, 2006.